Carrillo ER, Contreras CNA

Language: Spanish
References: 20
Page: 163-173
PDF size: 132.21 Kb.

ABSTRACT

Diastolic dysfunction is typically seen in patients with hypertensive, valvular heart disease, hypertrophic or restrictive cardiomyopathy and a variety of clinical disorders, especially tachycardia and ischemia. Has a particularly high prevalence in elderly patients and is generally associated, with low mortality but high morbidity. The pathophysiology of diastolic dysfunction includes delayed relaxation, impaired LV filling and/or increased stiffness. These conditions result typically in an upward displacement of the diastolic pressure–volume relationship with increased end-diastolic, left atrial and pulmo-capillary wedge pressure leading to symptoms of pulmonary congestion. Diagnosis of diastolic heart failure requires three conditions: (1) presence of signs or symptoms of heart failure; (2) presence of normal or slightly reduced LV ejection fraction (EF 50%) and (3) presence of increased diastolic filling pressure. Assessment of diastolic function can be performed with several non-invasive (2D- and Doppler-echocardiography, color Doppler M-mode, Doppler tissue imaging, MR-myocardial tagging, radionuclide ventriculography) and invasive techniques (micromanometry, angiography, conductance method). Doppler-echocardiography is the most useful tool to routinely measure diastolic function. Different techniques can be used alone or in combination to assess LV diastolic function, but most of them are dependent on heart rate, pre- and afterload. The transmitral flow pattern remains the starting point, since it is easy to acquire and rapidly categorizes patients into normal (E ›A), delayed relaxation (E ‹ A), and restrictive (E ›› A) filling patterns. The prognosis of diastolic heart failure is usually better than for systolic dysfunction. Diastolic heart failure is associated with a lower annual mortality rate of approximately 8% as compared to annual mortality of 19% in heart failure with systolic dysfunction. There is no specific therapy to improve LV diastolic function directly. Medical therapy of diastolic dysfunction is often empirical and lacks clear-cut pathophysiologic concepts. Nevertheless, there is growing evidence that calcium channel blockers, beta-blockers, ACE-inhibitors and AT2-blockers as well as nitric oxide donors can be beneficial. Treatment of the underlying disease is currently the most important therapeutic approach.

REFERENCES

1. García MJ. Diagnóstico y guía terapéutica de la insuficiencia cardiaca diastólica. Rev Esp Cardiol 2003;56 (4):396-406.

2. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-1955.

3. Cohn JN, Johnson G. Heart failure with normal ejection fraction. Circulation 1990;81:III48–11153.

4. Thomas JD. Diastolic suction is a major determinant of aerobic exercise capacity in heart failure patients. J Am Soc Echocardiogr 2002;15:479.

5. Cabrera SMC, Schmied P S, Vega S R, Semertzakis PI, De La Maza CJ. Intraoperative diastolic dysfunction as a risk factor for hemodynamic instability. Rev Med Chil 2007;135:1276-1281.

6. Takano H, Adachi H, Ohshima S, Taniguchi K, Kurabayashi M. Mechanisms and clinical implications of asymptomatic mitral regurgitation in patients with left ventricular dysfunction. Circ J 2008;72:115-119.

7. Gilman G, Nelson T, Hansen W, Khandheria B, Ommen S. Diastolic Function: A Sonographer’s Approach to the Essential Echocardiographic Measurements of Left Ventricular Diastolic Function. J Am Soc Echocardiogr 2007;20:199-209.

8. Tylor D. Diastolic function the necessary basics. J Diagn Med Sonogr 2006; 22:99-08.

9. Mandinov L, Eberli F, Seiler C. Diastolic heart failure. Cardiovascular Research 2000;45: 813-825.

10. Galderisi M. Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects. Cardiovascular Ultrasound 2005;3:9.

11. Kristen M. Prognosis in diastolic heart failure. Progress in Cardiovascular Diseases 2005;47:333-339.

12. Van Kraaij D. Diagnosing diastolic heart failure. The European Journal of Heart Failure 2002;4:419-430.

13. Martínez L, Almenar L. Técnicas de imagen en la insuficiencia cardiaca. Rev Esp Cardiol Supl. 2006;6:27F-45F.

14. Shamagian G. Prescripción de fármacos en la insuficiencia cardiaca. Rev Esp Cardiol 2005;58:381-388.

15. Macín SM. Función ventricular y evolución de la insuficiencia cardiaca descompensada. Rev Esp Cardiol 2004;57:45-52.

16. Segovia C. Etiología y evaluación diagnóstica en la insuficiencia cardiaca. Rev Esp Cardiol 2004;57:250-259.

17. Evangelista A. Guías de práctica clínica en ecocardiografía. Rev Esp Cardiol 2000;53:663-683.

18. Greyson C. Pathophysiology of right ventricular failure. Crit Care Med 2008;36:S57-S65.

19. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite- Moreira AF, Borbe´ly A, E´des I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-2550. 20. Oh JK, Hatle L, Tajik AJ, Little WC. Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol 2006;47:500-506.

20. Hasegawa H, Little WC, Ohno M, Brucks S, Morimoto A, Cheng H-J, Cheng C-P. Diastolic mitral annular velocity during the development of heart failure. J Am Coll Cardiol 2003;41:1590-1597.